We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Emis Group Plc | LSE:EMIS | London | Ordinary Share | GB00B61D1Y04 | ORD 1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 1,920.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 1,920.00 | GBX |
Emis (EMIS) Share Charts1 Year Emis Chart |
|
1 Month Emis Chart |
Intraday Emis Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 07/9/2023 10:02 by 1c3479z does today's announcement mean we collect the divi...have to hope so after cvsg price fall today! |
Posted at 11/8/2023 18:48 by stuffee Estimated value of offerI assume there will be no further objections to the CMA by interested parties up to the stipulated deadline of 5 Oct and the United Healthcare offer should complete by say end Oct with settlement in late Nov. The original announcement re the June 2022 offer of 1925p referred to shareholders retaining any subsequent dividends up to a final of 21.1p and interim of 17.6p. The final div for 2022 of 21.1p was paid on 11 July 2023. Last year's interim dividend of 17.6p was paid on 7 Oct 2022. I am sure at this time the parties never envisaged a 12 month delay before completion. I don't believe there has been any material change of circumstances over the last year, which could trigger a price change and I guess there will be strong moral pressure to permit shareholders to retain a 2023 interim div of 17.6p. On the basis of above, I asssume the aggregate consideration receivable in three months will be 1942p.This (just) seems compatible with the massive turnover today, (16.6m shares disclosed, compared to 63m shares in issue) traded at 1906 / 1910p; it might be interesting to see if any interesting discosures on Monday of major share purchases. |
Posted at 07/7/2023 09:31 by wad collector The trouble is that however strongly that UH and EMIS make a case, it hits the buffers of the CMA decision. Are they really likely to change their mind because silver-tongued lawyers argue that they are wrong? |
Posted at 26/6/2023 23:02 by stuffee Don't forget United Health is capitalised at over $400bn, so it could finance acquisitions of Amedisys ($3bn) and EMIS (£1bn) out of petty cash if it so wished. I don't therefore feel its announced offer for Amdisys will have any effect on potential offer for EMIS. |
Posted at 25/5/2023 08:51 by tomps2 EMIS Group (EMIS) Full Year 2022 results presentation - May 2023Emis CEO, Andy Thorburn & CFO, Peter Southby, present full-year 2022 results. Watch the video here: Or listen to the podcast here: |
Posted at 21/4/2023 09:37 by wad collector Interested to see the share price creeping slowly upwards in the last 10 days ; there will remain uncertainty about the bid situation for months. If you take out the whole bid issue, £16 is not an outrageous price for it's niche position but it is not cheap.The effect of a Labour Government on the business will not be as great as the effect of a Labour Govt on the share price I suspect .They say they will reverse the Lifetime Pension limit changes, they may curtail IHT AIM share rules, they may reduce ISA limits, they may further reduce dividend tax allowances. Who knows? Any Gov is going to have to to continue invest significantly in IT infrastructure so I think the income stream is secure here. |
Posted at 14/4/2023 22:40 by leucadia I would not like to predict whether the merger with United Healthcare will be completed but I think the CMA's concerns have confirmed the strategically important position EMIS has as a contractor to the NHS. For this reason I am willing to risk a loss if the United Healthcare bid is disallowed as I think this loss would eventually be recouped over the medium term owing to EMIS's competitive position. My guess is that a Labour government at the next election would eventually benefit EMIS owing to greater NHS spending and efforts to fix the NHS, and I wonder if others would agree with this assumption? |
Posted at 27/3/2023 14:39 by wad collector I don't think EMIS is going to pay a dividend ; it would have made that announcement with the results, and UH made it clear that they were not paying any more dividends as part of their offer beyond the last year's one.It appears from the share price that "the market" is not confident the takeover will happen given the current 135p gap. The CMA may not give a firm decision on Thursday , in which case I think the share price will drop a little further. If they approve, presumably the price will bounce to not far short of 1925p. I got rid of mine a few months ago when I couldn't see much upside, but I suspect there are quite a lot of PIs who may wish to take a Capital Gain in this tax year before the relief drops to £5k next year, so are debating whether to take the current price. |
Posted at 25/3/2023 12:43 by stuffee Thanks Gopher for your valuable observation re UH.I would like to think that after 9 months of detailed negotiations, research and no doubt endless reports to the CMA, UH won't give up now but pursue remedies to satisfy the CMA's concerns. UH's offer, as announced last June, was 1925p and in adddition it can pay a dividend of 22p, normally payable in May (ex date of 16 April last year). Current share prices generally not much different from June 2022 levels (FTSE 7,000/ 7,500). Most unlikely that the Take-over panel would allow any attempt to reduce price. There is reasonable upside from present price of 1800p if the CMA can be satisfied and the acquisition completes. I guess the price could fall to its pre bid level of c £14 (prospective PE of around 22) if UH can not provide suitable remedies and the offer lapses. EMIS has made commitment to recommend an offer at 1925p, and this might be invitation to other third parties who might be interested in acquiring EMIS. 80% of its revenue is recurring, which makes it highly attractive to any finacial buyer. Hopefully EMIS willl not have suffered from the uncertainty of the CMA investigation over recent months; its recent trading statements seemed reassuring. The CMA has to determine the acceptability of UH's undertakings by 31 March, when EMIS should hopefully annnounce progress. |
Posted at 06/11/2022 21:57 by wad collector Slippage in the timetable;Listed healthcare software developer EMIS Group, whose products are used across a number of major UK healthcare settings, has said it now expects its £1.24bn takeover to complete early next year. EMIS Group was established in North Yorkshire in 1987 and specialises in connected healthcare software and systems. Its products are used in primary care, community care, accident and emergency, and community and hospital pharmacies. The Leeds-based company employs about 1,400 staff, primarily in the UK (1,150) and India (250), and it reported revenues of approximately £168m in 2021. It was announced in June that Bordeaux UK Holdings II (Bidco), an affiliate of Optum Health Solutions (UK) (Optum UK) and a wholly owned subsidiary of UnitedHealth Group Incorporated (UnitedHealth Group) had reached an agreement with the board of EMIS Group on the terms and conditions of a recommended all cash offer. The proposed acquisition values the entire issued, and to be issued, ordinary share capital of EMIS at approximately £1.24bn. In August, EMIS Group shareholders voted to proceed with the takeover, and the secretary of state confirmed that no further action will be taken in relation to the acquisition. The group has now provided an update to the timetable for completion of the deal. It said the parties are currently in the process of finalising a Merger Notice with the Competition and Markets Authority (CMA), preliminary to a Phase One investigation of the Acquisition. As a result, unless the relevant condition is waived by Bidco, EMIS now expects the takeover scheme to become effective in the first quarter of 2023. Travers Smith is acting as legal adviser to EMIS, with Numis as financial adviser, corporate broker and nominated adviser, and MHP as PR adviser. Slaughter and May is acting as legal adviser to UnitedHealth Group and Bidco, with Robey Warshaw as financial adviser and FGS Global as PR adviser. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
